
Keywords: gene therapy; fibrosis; TGFbeta; myocardial infarction; AAV1; adeno-associated viral vector, serotype 1; AT1R; angiotensin II receptor 1; BZ; border zone; Ca2+; calcium ion; DAB; 3,3â²-diaminobenzidine; IZ; infarct zone; MCARD; molecular cardiac surgery